Look Past The Setbacks And Give Tenaya Therapeutics Inc (NASDAQ: TNYA) Another Chance

Tenaya Therapeutics Inc (NASDAQ:TNYA) currently has a daily average trading volume of 1.23M but it saw 6732606 shares traded in last market. With a market cap of 197.22M USD, the company’s current market price of $2.50 came rising about 12.11 while comparing to the previous closing price of $2.23. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.01 and as low as $1.61. In the recent trading on the day, stock has struck highest price mark of $2.29 while lowest mark touched by it was $2.795.

Taking a look at 20-day trading activity of Tenaya Therapeutics Inc (TNYA) gives us an average price of $1.99, while its current price level is -64.34% below from 52-week high level whereas it is 55.28% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.05 while that of 200 days or SMA-200 reads an average of $3.66. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.13% during that period while stretching the period over a month that decreases to 12.02%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 62.49 which implies that the stock is in neutral territory.

H.C. Wainwright also issued its recommendations for the stock as it initiated the price target for the stock is $25.

Over the week, TNYA’s stock price is moving 30.21% up while it is 45.35% when we observe its performance for the past one month. Year-to-date it is -22.84% down and over the past year, the stock is showing an upside performance of 21.95%.

Currently, Tenaya Therapeutics Inc’s total number of outstanding shares is 68.33M. Company’s return on investment (ROI) stands at -94.44% and return on equity (ROE) at -84.49%. Stock’s beta reads 2.38. Stock has a price to book (P/B) ratio of 1.76. Its return on asset (ROA) is -70.20% on average.